2020, Sept. 10-12: Gynecologic Pathology: Navigating Histologic Mimics and Other Diagnostic Pitfalls
Sept. 10-12, 2020 - Palm Springs, California
24 CMEs / 24 SAMs
Specimens from gynecologic organs constitute a significant component of most surgical pathology practices, which necessitates that practicing pathologists remain updated on advances in this dynamic, constantly evolving field. The diagnosis of gynecologic tract diseases can be challenging, and fraught with potential pitfalls that may have clinically significant consequences. Classical diagnostic issues in gynecologic pathology have revolved around the potential for non-neoplastic diseases, benign neoplasms, and malignancies to mimic each other, and for different histotypes of malignancies to display morphologic and/or immunophenotypic overlap. Within this context, pathologists must remain updated on newer approaches to disease classification, disease staging, and tumor grading. In this interactive microscopy course, the faculty will present cases wherein one lesion may potentially be mistaken for another due to varying degrees of morphologic and/or immunophenotypic overlap between them, or in which a cancer may be misclassified regarding grade, stage or primary site for a variety of reasons. The diverse case-mix will include those derived from both routine and consultation practices, reflecting the broad spectrum of gynecologic pathology. The presentation of cases will be clinically oriented, with an emphasis on day-to-day practical issues, and on accurately classifying each case within the context of a lesion-specific differential diagnosis.
- Identify tumor appearances that may result in errors in tumor typing, staging and grading
- Evaluate diagnostic criteria and clinical significance of various common and uncommon neoplasms of the gynecologic tract
- Recognize the utility and pitfalls associated with the use of immunohistochemistry to resolve some diagnostic issues
Oluwole Fadare, MD
University of California San Diego School of Medicine
- Mai P. Hoang, MD
Massachusetts General Hospital; Harvard Medical School
- Teri A. Longacre, MD
- Anais Malpica, MD
University of Texas MD Anderson Cancer Center
- Vinita Parkash, MBBS, MPH
Yale University School of Medicine
- Wenxin Zheng, MD
University of Texas Southwestern Medical Center
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this live activity for a maximum of 24 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Continuing Certification (CC).
Physicians can earn a maximum of 24 SAM credit hours.
USCAP records courses at the Interactive Learning Center for future educational purposes. By registering for this course, you consent that your likeness may be used by USCAP.
Cancellations will be assessed an administrative charge of 25% of the total registration fee. There will be no refunds for cancellations within 14 days of the event. The Academy is not responsible for travel expenses incurred as a result of an event cancellation.